User profiles for MADELON C. VONK
Madelon VonkVerified email at radboudumc.nl Cited by 16552 |
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative
Objective The 1980 American College of Rheumatology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
…, U Müller-Ladner, JE Pope, MC Vonk… - Annals of the …, 2014 - ard.bmj.com
Objective Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of death
in systemic sclerosis (SSc), facilitates earlier treatment. The objective of this study was to …
in systemic sclerosis (SSc), facilitates earlier treatment. The objective of this study was to …
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial
…, J Larghero, AJ Schuerwegh, EWA Marijt, MC Vonk… - Jama, 2014 - jamanetwork.com
Importance High-dose immunosuppressive therapy and autologous hematopoietic stem cell
transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small …
transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small …
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative
Objective. The 1980 American College of Rheuma-tology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
…, R Palomino-Morales, MJ Coenen, MC Vonk… - Nature …, 2010 - nature.com
Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of the skin and
internal organs that leads to profound disability and premature death. To identify new SSc …
internal organs that leads to profound disability and premature death. To identify new SSc …
[HTML][HTML] Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis
Capillaroscopy is a non-invasive and safe tool which allows the evaluation of the morphology
of the microcirculation. Since its recent incorporation in the 2013 American College of …
of the microcirculation. Since its recent incorporation in the 2013 American College of …
[HTML][HTML] Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy
…, M Teruel, LM Diaz-Gallo, JC Broen, MC Vonk… - PLoS …, 2011 - journals.plos.org
The aim of this study was to determine, through a genome-wide association study (GWAS),
the genetic components contributing to different clinical sub-phenotypes of systemic sclerosis …
the genetic components contributing to different clinical sub-phenotypes of systemic sclerosis …
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the …
Background In the Safety and Efficacy of Nintedanib in Systemic Sclerosis (SENSCIS) trial,
nintedanib reduced the rate of decline in forced vital capacity (FVC) in patients with systemic …
nintedanib reduced the rate of decline in forced vital capacity (FVC) in patients with systemic …
Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis
MC Vonk, Z Marjanovic, FHJ van den Hoogen… - Annals of the …, 2008 - ard.bmj.com
Objective: Systemic sclerosis (SSc) is a generalised autoimmune disease, causing morbidity
and a reduced life expectancy, especially in patients with rapidly progressive diffuse …
and a reduced life expectancy, especially in patients with rapidly progressive diffuse …
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
MJ Overbeek, MC Vonk, A Boonstra… - European …, 2009 - Eur Respiratory Soc
Systemic sclerosis-associated pulmonary arterial hypertension (SScPAH) has a worse
prognosis and response to pulmonary arterial hypertension (PAH) therapy than idiopathic PAH (…
prognosis and response to pulmonary arterial hypertension (PAH) therapy than idiopathic PAH (…